AT Charlie Johnson et al have developed a high-throughput screening test for cancer based on the analysis of volatile organic compounds (VOCs) in blood.
Peter Q Nguyen et al have developed a face mask with a lyophilised CRISPR sensor for wearable, non-invasive detection of SARS-CoV-2 infection.
Yaoheng Yang et al have developed a technique called sonothermogenetics, which combines ultrasound and genetic modification to achieve non-invasive neural control in deep brain regions.
Saba Atefyekta et al fabricated a new antimicrobial peptide (AMP) based wound dressing material that could reduce infection and promote blood coagulation and healing.
Adi Idris et al have developed a new therapeutic approach using small-interfering RNAs (siRNAs) targeted specifically to SARS-CoV-2, the virus causing the COVID-19 infection.
Jongkyeong Lim et al have developed a new technique to treat cerebral aneurysms. The treatment involves a catheter to deliver an alginate hydrogel microfibre that is crosslinked in place within the aneurysm using light.
Sabina Kaczanowska et al developed genetically engineered myeloid cells (GEMys) that could help alter the metastatic environment of a tumour and prevent it from spreading.